8-K: WNS (Holdings) Limited Advances Capgemini Acquisition with Scheme Document Publication and Shareholder Meeting Dates
Acquisition Update
WNS (Holdings) Limited has published the scheme circular and set August 29, 2025, for shareholder meetings to approve its acquisition by Capgemini S.E. for $76.50 per share in cash.
Summary
- WNS (Holdings) Limited (WNS) is being acquired by Capgemini S.E. (Capgemini) for $76.50 per share in cash, to be implemented via a scheme of arrangement under Jersey law.
- The acquisition price of $76.50 per share represents a premium of approximately 28% to WNS's 90-day volume weighted average closing price, 27% to its 30-day volume weighted average closing price, and 17% to its closing price on July 3, 2025.
- The transaction requires approval from WNS shareholders at both a Court Meeting and a General Meeting, scheduled for August 29, 2025, in London.
- WNS Directors, holding approximately 1.21% of the issued share capital, have irrevocably undertaken to vote in favor of the Scheme Resolution and the General Meeting Resolution.
- WNS's share plans will be terminated upon the acquisition's effectiveness, with vested restricted stock units (RSUs) and 20% of unvested RSUs converting to cash at the acquisition price; remaining unvested RSUs will become Modified Unvested Awards payable according to their original vesting schedules.
- A transaction bonus program of up to $10 million (less taxes) has been granted to certain employees, with CEO Keshav R. Murugesh eligible for $1 million.
- Capgemini will fund the acquisition through a combination of available cash and committed debt financing, including a $3.7 billion unsecured term loan facility.
- WNS shares are expected to be delisted from the NYSE shortly after the acquisition becomes effective, and WNS intends to re-register as a private company.
- The Scheme is currently expected to become effective by the end of 2025, with a long stop date of April 7, 2026, extendable to August 6, 2026, under certain conditions.
Sentiment
Score: 9
Explanation: The sentiment is highly positive for WNS shareholders due to the significant cash premium offered, the unanimous board recommendation, and the high certainty of closing given the committed financing and irrevocable undertakings. The acquisition provides immediate, certain value.
Positives
- The acquisition provides WNS shareholders with immediate value and liquidity through a cash consideration of $76.50 per share.
- The offer price represents a significant premium over recent trading prices: 28% over the 90-day volume weighted average, 27% over the 30-day volume weighted average, and 17% over the closing price on July 3, 2025.
- The WNS Board unanimously recommends the acquisition, indicating strong internal support for the terms.
- The acquisition is expected to position the combined WNS and Capgemini groups as a leader in the Intelligent Operations market, enhancing capabilities in digital transformation, AI, and business outcomes.
- Capgemini has secured committed debt financing, providing a high degree of certainty regarding the funding of the acquisition.
- WNS retains the ability, under certain circumstances, to engage with and potentially accept a superior unsolicited acquisition proposal prior to the shareholder meetings.
Negatives
- WNS shareholders will not participate in any future growth potential or benefit from any future increase in the value of WNS as a standalone entity.
- The public announcement and pendency of the acquisition could negatively affect WNS's business relationships, operating results, and ability to retain key personnel.
- Restrictions on WNS's business operations prior to the acquisition's consummation may delay or prevent the company from pursuing new business opportunities.
- Significant costs are involved in connection with entering into the Transaction Agreement and completing the acquisition, many of which are payable regardless of whether the transaction is consummated.
- The acquisition may divert significant management time and attention, potentially disrupting normal business operations and negatively impacting financial results.
- If Capgemini fails to complete the acquisition due to a breach of the Transaction Agreement in certain circumstances, WNS's remedies may be limited to a termination fee of $118 million.
Risks
- The acquisition may not be consummated on a timely basis or at all.
- Various conditions to the acquisition's consummation may not be satisfied or waived, including failure to receive required shareholder approval or regulatory approvals.
- Regulatory approvals may come with conditions, limitations, or restrictions.
- An event, change, or other circumstance could give rise to the termination of the Transaction Agreement.
- The announcement or pendency of the proposed transaction could negatively affect WNS's business relationships, operating results, and business generally.
- The proposed transaction may disrupt WNS's current plans and operations.
- Potential difficulties in WNS's employee retention may arise as a result of the proposed transaction.
- There may be liabilities that are not known, probable, or estimable at this time, or unexpected costs, charges, or expenses.
- The acquisition may result in the diversion of management's time and attention to issues relating to the transaction.
- Significant transaction costs are associated with the acquisition.
- Unfavorable outcomes of legal proceedings may be instituted against WNS following the announcement of the acquisition.
- WNS's stock price may decline significantly if the proposed acquisition is not consummated.
Future Outlook
The acquisition is expected to become effective by the end of 2025, subject to shareholder and regulatory approvals. Upon completion, WNS will become a wholly-owned subsidiary of Capgemini, and its shares will be delisted from the NYSE, with WNS re-registering as a private company. The combined entity aims to be a leader in the Intelligent Operations market, leveraging digital, AI, and data capabilities.
Management Comments
- The WNS Board unanimously determined that the Transaction Agreement and the consummation of the Acquisition are advisable and fair to, and in the best interests of, WNS and its shareholders.
- The WNS Board believes that the $76.50 per share in cash payable in the Acquisition provides certainty, immediate value, and liquidity to WNS Shareholders.
- The WNS Board views the $76.50 per share as more favorable on a risk-adjusted basis than potential value from other reasonably available alternatives, based on their knowledge of WNS's business, assets, financial condition, and competitive position.
- The WNS Board believes, after extensive negotiations, that $76.50 per share was the highest price Capgemini was willing to pay and that the terms are the most favorable to WNS.
- The WNS Board, advised by J.P. Morgan, believes the financial terms of the Acquisition are fair and reasonable.
Industry Context
This acquisition reflects a broader trend in the business transformation and services industry towards consolidation and the integration of digital, AI, and data capabilities. Capgemini, a global business and technology transformation partner, is enhancing its 'Intelligent Operations' market leadership by acquiring WNS's deep domain expertise, advanced technologies, and global talent. This move aims to address client goals for efficiency, speed, and agility through hyper-automation and improved business outcomes, indicating a strategic focus on end-to-end digital solutions and AI-driven services within the sector.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Executive Officer | NA | Keshav R. Murugesh | 2025-07-22 | Employment term extended until the earlier of August 5, 2026, or the Closing Date, in connection with the acquisition. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Articles of Association Amendment | Proposed amendment to ensure WNS Shares issued between the Voting Record Time and Scheme Record Time are subject to the Scheme, and shares issued after the Scheme Record Time are automatically acquired by Capgemini on the same terms. | Upon passing of the special resolution at the General Meeting | Ensures all shares, including those from incentive plans, are included in the acquisition terms, preventing potential holdouts or complications in the transfer of full ownership to Capgemini. |
Legal Proceedings
- Risk of unfavorable outcome of legal proceedings that may be instituted against WNS following the announcement of the Acquisition.
Related Party Transactions
- Transaction bonuses granted to certain employees, including CEO Keshav R. Murugesh ($1,000,000), are tied to the acquisition's consummation.
Stakeholder Impact
- Shareholders: Will receive a cash premium for their shares, providing immediate liquidity but foregoing future potential growth of WNS as an independent entity. No appraisal rights are available.
- Employees: Certain employees will receive transaction bonuses. There is a risk of potential difficulties in employee retention due to the proposed transaction. Some WNS management may be offered positions at Capgemini.
- Customers and Partners: The announcement and pendency of the acquisition could potentially disrupt WNS's business relationships with customers and partners.
- Management: Time and attention of WNS management will be diverted to issues relating to the acquisition.
Next Steps
- WNS Shareholders are requested to complete and return Forms of Proxy for the Court Meeting and General Meeting by August 27, 2025.
- The Court Meeting will be held on August 29, 2025, at 2:00 p.m. (London Time) to approve the Scheme.
- The General Meeting will be held on August 29, 2025, at 2:15 p.m. (London Time) to approve the Resolution to facilitate the Scheme and amend Articles of Association.
- WNS will disclose the date of the Court Sanction Hearing by public announcement and SEC filing at least 14 days before the hearing.
- The Scheme is expected to become effective by the end of 2025, subject to satisfaction or waiver of all relevant conditions.
- WNS will request the NYSE to cancel the listing and trading of WNS Shares on or shortly after the Effective Date.
- As soon as practicable after the Effective Date and delisting, WNS intends to be re-registered as a private company limited by shares.
Key Dates
| Date | Description |
|---|---|
| 2006-07-26 | WNS completed its initial public offering on the New York Stock Exchange, pricing at $20.00 per American Depositary Share. |
| 2024-12-01 | WNS received a non-binding letter of intent from a financial sponsor (Party A) to acquire WNS for $65.00 per share. |
| 2025-02-29 | WNS received a non-binding offer from a strategic company (Party B) to acquire WNS in a cash/stock transaction valued at $72.00 per share. |
| 2025-03-01 | WNS Board agreed to a period of exclusivity with Capgemini following a non-binding offer and provided access for due diligence. |
| 2025-04-30 | Talks between WNS and Capgemini paused due to a disagreement on price. |
| 2025-06-15 | WNS re-engaged in discussions with Capgemini. |
| 2025-06-30 | Date of WNS's last published interim consolidated financial statements. |
| 2025-07-03 | Last Business Day immediately prior to the public announcement of the acquisition, used for premium calculations. |
| 2025-07-06 | Transaction Agreement entered into between WNS and Capgemini; Capgemini entered into a bridge term loan facilities agreement. |
| 2025-07-07 | Acquisition announced; Announcement 8-K filed with the SEC. |
| 2025-07-16 | Bridge Facilities Agreement amended. |
| 2025-07-21 | Grant date for restricted stock units to several WNS Directors. |
| 2025-07-22 | WNS and Mr. Murugesh agreed to extend his employment term until August 5, 2026, or the Closing Date. |
| 2025-07-25 | Latest Practicable Date before publication of the Scheme Document (10:00 p.m. London Time). |
| 2025-07-29 | Directions Hearing; Record Date/Beneficial Holder Record Time for shareholder meetings (10:00 p.m. London Time). |
| 2025-07-30 | Date of Report; Press Release issued; Scheme Document published. |
| 2025-07-31 | Scheme Document available for inspection on WNS investor relations site (first Business Day following publication). |
| 2025-08-27 | Latest time for lodging Forms of Proxy for Court Meeting (2:00 p.m. London Time) and General Meeting (2:15 p.m. London Time); Voting Record Time for the Court Meeting and General Meeting (10:00 p.m. London Time). |
| 2025-08-29 | Court Meeting (2:00 p.m. London Time) and General Meeting (2:15 p.m. London Time) to be held in London. |
| 2025-12-31 | Scheme is currently expected to become effective by the end of 2025. |
| 2026-04-07 | Long Stop Date for the Scheme to be implemented. |
| 2026-08-06 | Latest possible extended Long Stop Date (thirteen months from the Transaction Agreement date). |
Recommendation
strong buyThe filing details a definitive acquisition agreement where WNS shareholders will receive $76.50 per share in cash. This represents a substantial premium over recent trading prices (17% over the last closing price before announcement, and higher over 30-day and 90-day averages). The WNS Board unanimously recommends the deal, and Capgemini has secured committed financing, indicating a high probability of successful completion. For investors, this offers a clear, immediate, and attractive cash exit at a premium, making it a strong buy for arbitrage or to capture the premium.
Keywords
WNS Holdings, Capgemini, Acquisition, Scheme of Arrangement, Merger, Business Transformation, Digital Services, SEC Filing, Shareholder Vote, Delisting, Corporate Action
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.